Designing Clinical Trials in a Post Neo-Adjuvant Setting
نویسندگان
چکیده
منابع مشابه
Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials
The clinical benefits of endocrine therapy for patients with hormonosensitive breast cancer are well established. For many years, 5 years of tamoxifen was the gold standard of adjuvant treatment. The recent development of new endocrine agents provides physicians with a more effective therapeutic approach. Nevertheless, the success of neoadjuvant endocrine therapy is much more recent and less re...
متن کاملDesigning clinical trials for amblyopia
Randomized clinical trial (RCT) study design leads to one of the highest levels of evidence, and is a preferred study design over cohort studies, because randomization reduces bias and maximizes the chance that even unknown confounding factors will be balanced between treatment groups. Recent randomized clinical trials and observational studies in amblyopia can be taken together to formulate an...
متن کاملDesigning future clinical trials in acute pancreatitis.
Accessible online at: www.karger.com/pan Overall disease-related mortality from an episode of acute pancreatitis is approximately 10% [1]. There are no specific therapies for acute pancreatitis apart from prophylactic antibiotics [2] and endoscopic sphincterotomy [3] for severe gallstone-related disease. The failure of the recent multi-centre study of the platelet activating factor antagonist l...
متن کاملDesigning clinical trials in trauma surgery
The surgical community is plagued with a reputation for both failing to engage and to deliver on clinical research. This is in part due to the absence of a strong research culture, however it is also due to a multitude of barriers encountered in clinical research; particularly those involving surgical interventions. 'Trauma' amplifies these barriers, owing to the unplanned nature of care, unpre...
متن کاملDesigning clinical trials in older people.
Adequate medical care of the increasingly ageing population requires robust clinical trial data both to inform treatment decisions, and to understand the natural history of diseases which primarily affect the elderly. However, this information is widely lacking, which is likely to have significant clinical consequences. Under-representation of older people in clinical trials is well documented,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2014
ISSN: 0923-7534
DOI: 10.1093/annonc/mdu291.4